Prostate focal peripheral zone lesions: Characterization at multiparametric MR imaging-influence of a computer-aided diagnosis system1

Radiology

Volumn 271, Issue 3, 2014, Pages 761-769

  Niaf, Emilie ^a,b,c,d   Lartizien, Carole ^d   Bratan, Flavie ^a,b,c,e   Roche, Laurent ^b,c,e,g   Rabilloud, Muriel ^b,c,e,g   Mège Lechevallier, Florence ^f   Rouvière, Olivier ^a,b,c,e  

^a LABTAU   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITÉ DE LYON   (France)

^e HOSPICES CIVILS DE LYON   (France)

^f Department of Pathology ^*  (France)

^g EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; DYNAMIC CONTRAST MATERIAL ENHANCED IMAGING; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; MIDDLE AGED; MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSTATE DISEASE; PROSTATE FOCAL PERIPHERAL ZONE LESION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; T2 WEIGHTED IMAGING; TUMOR CLASSIFICATION;

AGED; AREA UNDER CURVE; CONTRAST MEDIA; DIAGNOSIS, COMPUTER-ASSISTED; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; OBSERVER VARIATION; ORGANOMETALLIC COMPOUNDS; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; ROC CURVE;

EID: 84901666584     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14130448     Document Type: Article

References (40)

1. Fütterer JJ, Heijmink SW, Scheenen TW, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006;241(2):449-458.
2. Yoshimitsu K, Kiyoshima K, Irie H, et al. Usefulness of apparent diffusion coeffcient map in diagnosing prostate carcinoma: correlation with stepwise histopathology. J Magn Reson Imaging 2008;27(1):132-139.
3. Yoshizako T, Wada A, Hayashi T, et al. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Acta Radiol 2008;49(10):1207-1213.
4. Lim HK, Kim JK, Kim KA, Cho KS. Prostate cancer: apparent diffusion coeff-cient map with T2-weighted images for detection-a multireader study. Radiology 2009;250(1):145-151.
5. Puech P, Potiron E, Lemaitre L, et al. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intrapros-tatic prostate cancer: correlation with radical prostatectomy specimens. Urology 2009;74(5):1094-1099.
6. Girouin N, Mège-Lechevallier F, Tonina Senes A, et al. Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable? Eur Radiol 2007;17(6):1498-1509.
7. Cheikh AB, Girouin N, Colombel M, et al. Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy. Eur Radiol 2009;19(3):770-778.
8. Turkbey B, Pinto PA, Mani H, et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection-histopathologic correlation. Radiology 2010;255(1):89-99.
9. Bratan F, Niaf E, Melodelima C, et al. In-fuence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol 2013;23(7):2019-2029.
10. Dickinson L, Ahmed HU, Allen C, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 2011;59(4): 477-494.
11. Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol 2012;22(4):746-757.
12. Rouvière O, Papillard M, Girouin N, et al. Is it possible to model the risk of malignancy of focal abnormalities found at prostate mul-tiparametric MRI? Eur Radiol 2012;22(5): 1149-1157.
13. Puech P, Rouvière O, Renard-Penna R, et al. Prostate cancer diagnosis: multiparamet-ric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy-prospective multicenter study. Radiology 2013;268(2):461-469.
14. Rosenkrantz AB, Kim S, Lim RP, et al. Prostate cancer localization using multiparamet-ric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales. Radiology 2013;269(2): 482-492.
15. Chan I, Wells W 3rd, Mulkern RV, et al. Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging: a multichannel statistical classifer. Med Phys 2003; 30(9):2390-2398.
16. Madabhushi A, Udupa JK, Moonis G. Comparing MR image intensity standardization against tissue characterizability of magnetization transfer ratio imaging. J Magn Reson Imaging 2006;24(3):667-675.
17. Viswanath S, Bloch BN, Genega E, et al. A comprehensive segmentation, registration, and cancer detection scheme on 3 Tesla in vivo prostate DCE-MRI. Med Image Com-put Comput Assist Interv 2008;11(Pt 1): 662-669.
18. Tiwari P, Rosen M, Madabhushi A. A hierarchical spectral clustering and nonlinear dimensionality reduction scheme for detection of prostate cancer from magnetic resonance spectroscopy (MRS). Med Phys 2009;36(9): 3927-3939.
19. Liu X, Langer DL, Haider MA, Yang Y, Wernick MN, Yetik IS. Prostate cancer segmentation with simultaneous estimation of Markov random feld parameters and class. IEEE Trans Med Imaging 2009;28(6):906-915.
20. Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haider MA. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 2009;30(2):327-334.
21. Puech P, Betrouni N, Makni N, Dewalle AS, Villers A, Lemaitre L. Computer-assisted diagnosis of prostate cancer using DCE-MRI data: design, implementation and preliminary results. Int J CARS 2009;4(1):1-10.
22. Ozer S, Langer DL, Liu X, et al. Supervised and unsupervised methods for prostate cancer segmentation with multispectral MRI. Med Phys 2010;37(4):1873-1883.
23. Artan Y, Haider MA, Langer DL, et al. Prostate cancer localization with multispectral MRI using cost-sensitive support vector machines and conditional random felds. IEEE Trans Image Process 2010;19(9):2444-2455.
24. Lopes R, Ayache A, Makni N, et al. Prostate cancer characterization on MR images using fractal features. Med Phys 2011;38(1):83-95.
25. Vos PC, Hambrock T, Barenstz JO, Huisman HJ. Computer-assisted analysis of peripheral zone prostate lesions using T2-weighted and dynamic contrast enhanced T1-weight-ed MRI. Phys Med Biol 2010;55(6):1719-1734.
26. Niaf E, Rouvière O, Mège-Lechevallier F, Bratan F, Lartizien C. Computer-aided diagnosis of prostate cancer in the peripheral zone using multiparametric MRI. Phys Med Biol 2012;57(12):3833-3851.
27. Peng Y, Jiang Y, Yang C, et al. Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score-a computer-aided diagnosis development study. Radiology 2013;267(3):787-796.
28. Hambrock T, Vos PC, Hulsbergen-van de Kaa CA, Barentsz JO, Huisman HJ. Prostate cancer: computer-aided diagnosis with mul-tiparametric 3-T MR imaging-effect on observer performance. Radiology 2013;266(2): 521-530.
29. Samaratunga H, Montironi R, True L, et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling. Mod Pathol 2011;24(1):6-15.
30. Alonzo TA, Pepe MS. Distribution-free ROC analysis using binary regression techniques. Biostatistics 2002;3(3):421-432.
31. Pepe MS. The statistical evaluation of medical tests for classifcation and prediction. Oxford, England: Oxford University Press, 2003.
32. Ahmed HU, Kirkham A, Arya M, et al. Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol 2009;6(4):197-206.
33. Lindner U, Trachtenberg J, Lawrentschuk N. Focal therapy in prostate cancer: modalities, fndings and future considerations. Nat Rev Urol 2010;7(10):562-571.
34. Rouvière O, Gelet A, Crouzet S, Chapelon JY. Prostate focused ultrasound focal therapy: imaging for the future. Nat Rev Clin Oncol 2012;9(12):721-727.
35. Vourganti S, Rastinehad A, Yerram NK, et al. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol 2012;188(6):2152-2157.
36. Sonn GA, Chang E, Natarajan S, et al. Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specifc antigen. Eur Urol 2013 Mar 17. [Epub ahead of print]
37. Akin O, Sala E, Moskowitz CS, et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006;239(3):784-792.
38. Hoeks CM, Hambrock T, Yakar D, et al. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. Radiology 2013;266(1):207-217.
39. Oto A, Kayhan A, Jiang Y, et al. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 2010;257(3): 715-723.
40. Chesnais AL, Niaf E, Bratan F, et al. Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: evaluation of discriminant criteria at multiparametric MRI. Clin Radiol 2013;68(6):e323-e330.